PDSB (pdsbiotech.com) Long-Term Debt

Corporate emblem and logo of PDS Biotech (PDSB)

This price chart for PDS Biotechnology (PDSB) reflects the price action of a biotech developer creating methods to combat HPV tumors by training the body to locate metastases. The company's operations rely on targeted medicine and the successful completion of medical trials. The current debt load stands at 0.00, which is typical for the research investment stage in the absence of commercial sales and amid rising costs.

PDSB (PDS Biotechnology Corporation) Company Long-Term Debt history from 07/04/2022 to 10/28/2026

Financial and market metric breakdowns for PDS Biotechnology Corporation (PDSB)

- price and consensus price forecast:
Stock Quotes PDS Biotech|PDSB - Price Target Chart
- market capitalization data:
Market Value PDS Biotechnology|PDSB - Total Company Value
- book capitalization data:
Net Assets per Single Share PDS Biotechnology|PDSB - Company Book Value|Market-to-Book Ratio pdsbiotech.com|PDSB - Company Total Assets
- debt and liquidity data:
Debt to Capital Ratio PDS Biotechnology|PDSB - Long-Term Debt to Equity Ratio|Current Liabilities to Capital PDS Biotech|PDSB - Company Total Debt|Debt to Net Assets Ratio PDS Biotechnology|PDSB - Company Long-Term Debts|Short-Term Debt Volume PDS Biotechnology
Comprehensive company analysis:PDSB (PDS Biotechnology)
Mass-produced product of pdsbiotech.com

The development of the Versamune platform and patient retention in clinical phases require significant funding to ensure therapy safety. This indicator aggregates obligations with maturities exceeding one year, reflecting the long-term credit load and the pace of borrowed capital utilization, which allows investors to assess the financial stability of PDS Biotechnology (PDSB) through the volume of the corporation's long-term loans and borrowings.

Competing companies

immunitybio.com - Company Long-Term Liabilities|IMCR (Immunocore) - Company Long-Term Debt|JANX: Long-Term Debt|Arcus Bio (RCUS) - Company Long-Term Debt|ZYME (Zymeworks Biopharmaceuticals) - Company Long-Term Debt|Company Long-Term Debt TNGX (Tango Therapeutics)|Long-Term Debt iovance.com|IMTX: Company Long-Term Debts|Long-Term Indebtedness Xencor Inc XNCR|CMPX: Company Long-Term Liabilities|REPL - Long-Term Debt|Company Long-Term Liabilities Lyell Immunopharma (LYEL)|IPHA - Company Long-Term Loans and Borrowings|pyxisoncology.com - Company Long-Term Debts|CGEN (Compugen) - Long-Term Debt Volume|Company Long-Term Debt IOBT|Company Long-Term Liabilities STRO|Company Long-Term Debt INKT (MiNK Therapeutics, Inc.)|Company Long-Term Liabilities werewolftx.com HOWL|Company Long-Term Liabilities IMMX (Immix Biopharma)|alxoncology.com - Company Long-Term Debts|Cue Biopharma (CUE) - Company Long-Term Debt|SONN: Company Long-Term Indebtedness|Company Long-Term Debt MAIA|Long-Term Debt liminatuspharma.com|LAVA Therapeutics NV - Company Long-Term Liabilities|Long-Term Indebtedness NextCure Inc (NXTC)|Company Long-Term Liabilities Leap Therapeutics, Inc.|Amount of Long-Term Liabilities intensitytherapeutics.com (INTS)|Company Long-Term Debts Sensei Biotherapeutics, Inc.|Company Long-Term Loans and Borrowings therivabio.com TOVX|GRTS (Gritstone Bio) - Company Long-Term Debts|KA: Long-Term Debt|Company Long-Term Debt NexImmune Corp NEXI|Turnstone Biologics Corp. (TSBX) - Company Long-Term Loans and Borrowings|VCNX (Vaccinex, Inc.) - Company Long-Term Debts|Company Long-Term Debts HARP